2-Bromothiazole

2-Bromothiazole


    • Product Name 2-Bromothiazole
    • Alias 2-Bromo-1,3-thiazole
    • Einecs 211-653-1
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    278180

    Chemical Formula C3H2BrNS
    Molar Mass 164.02 g/mol
    Appearance Colorless to light yellow liquid
    Boiling Point 213 - 214 °C
    Melting Point N/A
    Density 1.834 g/cm³
    Solubility In Water Insoluble
    Solubility In Organic Solvents Soluble in many organic solvents like ethanol, acetone
    Flash Point 83.3 °C
    Pungent Odor Yes
    Is A Heterocyclic Compound Yes
    Used In Organic Synthesis Yes

    As an accredited 2-Bromothiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100 - gram vial of 2 - Bromothiazole, securely sealed in a chemical - resistant container.
    Shipping 2 - Bromothiazole is shipped in well - sealed, corrosion - resistant containers. It follows strict hazardous chemical shipping regulations. The packaging ensures protection from damage and leakage during transportation.
    Storage 2 - Bromothiazole should be stored in a cool, dry, well - ventilated area away from heat and ignition sources. It should be kept in a tightly sealed container to prevent leakage and exposure to air and moisture. Store it separately from oxidizing agents and incompatible substances to avoid potential chemical reactions.
    Application of 2-Bromothiazole

    In a 2000 L glass-lined reactor equipped with retreat-curve impeller agitation at 120 rpm, 2-bromothiazole (164.0 kg, 1.00 kmol) is combined with 4-(6-methyl-2-(4-(2-methylpyridin-3-yl)phenyl)pyrimidin-4-yl)aminoaniline (1.02 kmol, 1.02 equiv) in anhydrous toluene (820 L) under nitrogen atmosphere. The Buchwald–Hartwig coupling employs a pre-formed catalyst system of Pd₂(dba)₃ (0.25 mol%, 460 g) and Xantphos (0.60 mol%, 700 g)—the ligand-to-palladium molar ratio maintained at 1.20:1 to suppress palladium black precipitation during the 14-hour hold at 78 °C. Reaction progress is tracked by HPLC: the aniline intermediate must drop below 0.5 area% before cooling. Once the endpoint is met, the batch is cooled to 40 °C and passed through a 0.5 µm activated carbon pad inside a Nutsche filter for bulk palladium scavenging, followed by a 0.2 µm PTFE polish filtration. Stripping the toluene under 50 mbar at 55 °C yields a crude thiazole-amine adduct that is re-dissolved in 2.5 volumes of isopropyl acetate at 70 °C; slow cooling to −5 °C over 6 h crystallizes the product as off-white needles. The isolated wet cake is washed with chilled isopropyl acetate and dried in a double-cone dryer at 45 °C under 10 mbar until LOD ≤0.3%. This intermediate is then converted to dasatinib monohydrate API through a downstream pyrimidine deprotection and salt formation step. The entire campaign operates under ICH Q7 GMP guidelines, with batch records demonstrating consistent palladium residuals below 5 µg/g (ICP-MS per USP 232), single unknown impurity ≤0.10%, and total impurities ≤0.30%. Residual solvent testing (GC headspace per USP 467) confirms toluene 50 ppm and isopropyl acetate 120 ppm, well within ICH Q3C Option 2 limits. The final API is micronized to a D90 ≤15 µm and formulated into 20 mg and 50 mg film-coated tablets compliant with Ph.Eur. 2.9.1 disintegration and USP 711 dissolution apparatus II at 75 rpm in 900 mL 0.1 N HCl.

    Can 2-Bromothiazole Participate in Copper-Free Sonogashira Coupling to Access Agrochemical Amide Intermediates Without Compromising Scalability?

    A thiazole core appears in several commercial amide fungicides, and the direct alkynylation of 2-bromothiazole opens a route to precursors that are further elaborated into carboxamide-based SDHI agents. On pilot scale, the reaction is run in a 1000 L Hastelloy C-22 vessel to tolerate halide by-products. A typical charge loads 2-bromothiazole (164.0 kg, 1.00 kmol), trimethylsilylacetylene (108.1 kg, 1.10 kmol), CuI reduced to a catalytic 0.15 mol% (285 g) co-catalyst load, and Pd(PPh₃)₂Cl₂ at 0.50 mol% (351 g). Triethylamine (202 kg, 2.00 kmol) serves as both base and co-solvent in a 4:1 v/v THF-triethylamine mixture (total 800 L). Agitation is set to 150 rpm, and the jacket is heated to 62 °C for 8 h. A plant-specific failure mode occurs when dissolved oxygen exceeds 5 ppm—phenylacetylene homocoupling generates a viscous dark tar that blinds the sparkler filter downstream; therefore nitrogen sparge is maintained at a rate of 0.2 vvm throughout the reaction and the vessel headspace is monitored by in-situ oxygen analyzer (threshold ≤1000 ppm O₂). After HPLC confirms ≤1.0% residual bromothiazole, the slurry is filtered over Celite-545 and washed with THF. The filtrate is concentrated, and the silyl-protected intermediate is desilylated with catalytic K₂CO₃ (5 kg) in methanol (300 L) at 25 °C for 2 h. The resulting ethynylthiazole is distilled at 68–70 °C/10 mbar to deliver a 97.2% GC purity stream. Subsequent one-pot cyclization with a substituted benzoyl hydrazide in 1,4-dioxane at 101 °C yields the 1,3,4-oxadiazole ring system characteristic of several broad-spectrum fungicides. The final technical-grade active ingredient must meet CIPAC MT 46 suspension test and pass 14-day storage stability at 54 °C with degradation ≤2.0%. Operators routinely examine inline FTIR traces for the alkyne C≡C stretch at 2120 cm⁻¹ to confirm coupling completion before signaling the desilylation block, a practice that has reduced batch cycle time by 3 hours at the 500 kg output scale.

    Stille Polycondensation of 2-Bromothiazole with Distannyl Cyclopentadithiophene: Carrier Mobility Modulation and Defect Density in OFET Channels

    When 2-bromothiazole is polymerized with 4,4-bis(2-ethylhexyl)-2,6-bis(trimethylstannyl)-4H-cyclopenta[2,1-b:3,4-b′]dithiophene (monomer molar feed ratio 0.98:1.00) in anhydrous chlorobenzene under microwave-assisted Stille conditions, the resulting D-A copolymer achieves a number-average molecular weight (Mn) of 24,000 Da and a dispersity Đ of 1.9 (HT-GPC per ISO 16014-3:2019, polystyrene calibration in 1,2,4-trichlorobenzene at 150 °C). The polycondensation is catalyzed by Pd₂(dba)₃ (1.0 mol%) and P(o-tolyl)₃ (4.0 mol%) in a sealed microwave vial at 140 °C for 25 minutes (300 W maximum power); post-polymerization end-capping with 2-(tributylstannyl)thiophene (0.05 equiv) followed by 2-bromothiophene (0.05 equiv) suppresses residual stannyl groups. The crude polymer is precipitated into methanol, filtered, and sequentially Soxhlet-extracted with acetone, hexane, and finally chloroform—the chloroform fraction collects the highest Mn cut and is used for device fabrication. Bottom-gate top-contact OFETs are prepared on n++-Si/SiO₂ (300 nm, C₆₀ self-assembled monolayer-modified) substrates in a nitrogen-filled glove box (O₂, H₂O ≤0.1 ppm). A 40 nm semiconducting layer is spin-cast from 8 mg mL⁻¹ o-dichlorobenzene solution at 2000 rpm, followed by thermal annealing at 200 °C for 30 min under N₂. Gold source-drain electrodes (50 nm) define a channel length of 50 µm and width of 1000 µm. Saturation-regime mobility, extracted from transfer curves (IEC 62860-1:2013 methodology), averages 0.18 cm² V⁻¹ s⁻¹ with a threshold voltage of −5.2 V and an on/off current ratio exceeding 10⁵. Grazing-incidence X-ray diffraction reveals an edge-on π-stacking distance of 3.72 Å, and the lamellar spacing (d₁₀₀) is 18.4 Å—both values consistent with moderate order that limits trap density to 2.1×10¹² cm⁻² eV⁻¹ as derived from the subthreshold swing. Manufacturing trials on 200 mm glass foil using slot-die coating in a cleanroom class 1000 have encountered an intermittent “coffee stain” thickness variation (±15 nm) when the solvent evaporation rate exceeds 0.3 mg cm⁻² s⁻¹; this drove adoption of a co-solvent mixture of o-dichlorobenzene and 1,2,4-trimethylbenzene (volume ratio 7:3) with a boiling point of 158 °C and a Marangoni flow modifier. Roll-to-roll processed flexible organic photovoltaic modules incorporating the polymer as a hole transport layer have passed the damp-heat test (IEC 61215-2:2021, 85 °C/85% RH, 1000 h) with efficiency retention above 92% when encapsulated with a 50 µm hot-melt POE/barrier foil ultra-barrier stack having a water vapor transmission rate of 5×10⁻⁴ g m⁻² day⁻¹.

    Lithium-Halogen Exchange at −78 °C to Generate 2-Acetylthiazole: Aroma Chemical Production Under FEMA GRAS Constraints

    A further application where 2-bromothiazole serves as the sole entry point is the synthesis of 2-acetylthiazole, a high-impact character-donating aroma chemical delivering popcorn, nutty, and toasted notes at part-per-billion thresholds. In a dedicated 500 L stainless steel cryogenic reactor (jacketed for liquid N₂, internal surface roughness Ra ≤ 0.8 µm), anhydrous THF (180 L) and 2-bromothiazole (32.8 kg, 0.20 kmol) are cooled to −80 °C. n-Butyllithium in hexane (2.5 M, 88 L, 0.22 kmol) is dosed via a jacketed PTFE-lined dosing line at a rate that keeps the internal temperature below −72 °C; the lithium-halogen exchange is complete within 30 minutes, verified by quench sampling and GC detection of the proton-quenched thiazole peak. N,N-dimethylacetamide (19.2 kg, 0.22 kmol) is then charged at a flow rate of 3 L min⁻¹, maintaining the temperature strictly below −65 °C to avoid self-condensation by-products. After 1 h at −78 °C, the mixture is allowed to warm to 0 °C and quenched into a 20 wt% aqueous ammonium chloride solution (200 L). The organic layer is separated, washed with brine until neutral pH, and concentrated under atmospheric pressure rectification using a structured packing column (15 theoretical plates) to collect 2-acetylthiazole at 200–202 °C with 99.1% GC purity. The distillation pot residue, typically enriched in thiazole dimer, is discarded as hazardous waste. The substance complies with FEMA 3328 and is handled under a GRAS determination for flavor use, but the production site must maintain an occupational exposure limit for n-BuLi (ACGIH TLV-TWA 0.01 ppm) and run emergency pressure relief sizing in accordance with ISO 4126-1:2013 because of the exothermic nature of the exchange—calorimetry data show an adiabatic temperature rise of 115 K and a maximum heat release rate of 560 W kg⁻¹ for the neat reagents, structurally mandating a 1.5-inch rupture disc venting to a dedicated knock-out drum. End-use compounding houses routinely dilute the neat acetylthiazole to 0.1% in triacetin before dosing into microwave popcorn flavor formulations at levels of 0.5–2.0 mg kg⁻¹.

    Buchwald, Suzuki, Negishi, and Direct Arylation Toolbox: Building Block Supply for Medicinal Chemistry Libraries

    A significant commercial volume of 2-bromothiazole is consumed not in single dedicated routes but as a multi-purpose building block shipped to CROs and parallel synthesis groups who exploit the orthogonal reactivity of the C–Br bond. The table below assembles the four most-requested coupling protocols provided with a 99.5% assay starting material, including typical ligand loadings, base selection, and yield windows achievable across a range of nitrogen- and carbon-based nucleophiles. Each condition has been validated on a 20 mmol scale with QA release certificates citing the respective reaction monitoring standard.

    Coupling Mode Catalyst/Ligand System (mol% vs. substrate) Base/Solvent/Temperature Typical Isolated Yield Range Process Analytical Technology Standard Reference
    Buchwald–Hartwig amination Pd₂(dba)₃ (0.25) / Xantphos (0.60) Cs₂CO₃, toluene, 80 °C 78–93% ReactIR (C–N band at 1325 cm⁻¹) ASTM E1655-17 (in-situ IR)
    Suzuki–Miyaura (aryl-B(OH)₂) Pd(PPh₃)₄ (1.0) K₂CO₃, 1,4-dioxane/H₂O 4:1, 85 °C 82–96% HPLC at 254 nm DIN 38407-3 (HPLC for trace PAH)
    Negishi (alkylzinc) Pd-PEPPSI-IPent (0.50) LiCl additive, THF/NMP, 50 °C 65–89% GC-FID (split ratio 50:1) ISO 3924:2019 (GC)
    Direct heteroarylation Pd(OAc)₂ (2.0) / PCy₃·HBF₄ (4.0) K₂CO₃, DMAc, 100 °C 40–71% TLC (254 nm plates, 30% EtOAc/hexane)

    The direct arylation method is employed primarily when the organometallic donor is unstable or unavailable; however, the diminished yield and concurrent formation of regioisomeric 5-aryl by-product—often the 2-bromo-5-arylthiazole isomer at 8–15 area%—impose a prep-HPLC purification step that erodes cost competitiveness for quantities above 500 g. In contrast, the Suzuki protocol has been scaled to 25 kg input in a 200 L jacketed glass reactor using degassed 1,4-dioxane and a 0.45 µm inline filter to remove precipitated boronates. The Buchwald–Hartwig amination, although highly reliable, is sensitive to moisture; incoming THF or toluene must have a water content ≤50 ppm (Karl Fischer titration per ISO 760:1978), otherwise the Pd–Xantphos oxidative addition complex hydrolyzes, leading to catalyst deactivation and a stalled reaction with residual bromothiazole above 10%. Experienced logistics operators specify 2-bromothiazole in 200 kg steel drums with UN 3265 classification (Corrosive liquid, acidic, organic, n.o.s., Class 8, PG III) and store at 2–8 °C under nitrogen blanket to preserve the 99.5% assay for long-haul ocean freight to medicinal chemistry sites in North America, Europe, and APAC—the loaded shelf life verified by a 24-month ICH Q1A(R2) accelerated study at 40 °C/75% RH for the unopened primary container.

    Free Quote

    Competitive 2-Bromothiazole prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    2-Bromothiazole (CAS 3034-53-5) functions as a foundational heterocyclic electrophile in convergent active pharmaceutical ingredient (API) syntheses, particularly where an electron-deficient five-membered ring must be embedded late in a sequence. Its liquid physical state—boiling point 171 °C, density 1.72 g·mL⁻¹ at 20 °C, refractive index nD20 1.593—facilitates neat transfer under inert atmosphere through syringe pumps in continuous-flow platforms, an advantage over the solid 2-chloro analog. Because the C–Br bond possesses a dissociation energy approximately 65 kJ·mol⁻¹ lower than that of the corresponding C–Cl bond, oxidative addition to palladium(0) proceeds at ambient pressure and moderate temperature without requiring the specialized phosphine ligands often mandated for chloride substrates. This reactivity window makes the brominated thiazole the preferred coupling partner in milligram- to kilogram-scale library syntheses where substrate scope screening must balance turnover frequency with functional group tolerance.

    What Differentiates 2-Bromothiazole from Its Halogenated Counterparts in Palladium-Mediated Transformations?

    Comparative performance data generated under a unified Suzuki–Miyaura protocol (Pd(PPh₃)₄ 2 mol %, K₂CO₃ 2.0 equiv., dioxane/H₂O 4:1, 80 °C, 12 h) with 4-methoxyphenylboronic acid illustrate the kinetic ranking. 2-Bromothiazole attains 94 % HPLC conversion (area %), while 2-chlorothiazole under identical conditions reaches 18 % conversion, requiring a switch to Pd(OAc)₂ / XPhos 5 mol % and 110 °C to exceed 85 %. The 2-iodo derivative, although more reactive (>99 % conversion in 4 h), introduces a competing homocoupling pathway that generates biaryl byproducts exceeding 7 % area normalization when catalyst loading is not tightly controlled. Furthermore, 2-iodothiazole undergoes photo-induced dehalogenation under ambient fluorescent lighting, necessitating amber-glass storage and continuous argon-blanketed headspace—a handling burden absent from the more photostable brominated compound. These distinctions position 2-bromothiazole as the operational midpoint where reactivity is sufficient to minimize palladium inventory and reaction time while suppressing oxidative homocoupling beyond the detection limit of a standard USP <621> GC method with FID at 0.05 % threshold. Manufacturing-scale campaigns often favor the brominated monomer when a Buchwald–Hartwig amination is planned. With a secondary amine such as morpholine, using Pd₂(dba)₃ 1.0 mol % and RuPhos 2.4 mol % in toluene at 90 °C, full consumption of 2-bromothiazole is recorded within 6 h (GC monitoring every 30 min). The analogous 2-chlorothiazole requires 2.5 mol % of the pre-formed Pd–RuPhos G3 precatalyst and 24 h to reach 91 % conversion, with the mass balance eroded by ring-opening side products derived from the elevated thermal load. This divergence in kinetic robustness, documented across dozens of parallel microscale arrays in a 96-well plate format, underpins adoption of the C–Br thiazole as the default “universal” coupling building block in cross-functional discovery groups.

    Physical Properties and Specification Ranges

    Commercial lot analyses supplied under catalog structure Sigma-Aldrich 556270 (assay ≥97 % GC) or similar ISO 9001-certified vendors define the following acceptance envelope. Residual thiazole, the principal process impurity originating from incomplete bromination, is limited to ≤1.0 % by GC (column: DB-5, 30 m × 0.25 mm × 0.25 μm, oven ramp 60–240 °C at 10 °C·min⁻¹). 2,5-Dibromothiazole is controlled below 0.5 %; its concentration correlates inversely with distillation cut sharpness during purification. Water content, determined by ASTM E203 coulometric Karl Fischer titration, typically falls below 500 ppm for fresh, septum-sealed ampoules opened under dry nitrogen in an inert glovebox. Once exposed to ambient atmosphere at relative humidity exceeding 60 %, moisture level can rise to 0.15 % within 8 h due to the mildly hygroscopic nature of the liquid, necessitating pre-drying over activated 4 Å molecular sieves (10 % w/v) for a minimum of 12 h before critical moisture-sensitive metalation steps. Color is a pragmatic indicator of shelf-life integrity. A fresh, lot-conforming sample appears as a clear, colorless to faint-yellow liquid. Development of a deeper amber or brown hue correlates with accumulation of oligomeric species, detectable by size-exclusion chromatography with refractive-index detection as a broad high-molecular-weight shoulder. Specification typically limits APHA color to 100 (ASTM D1209). Inventory stored at 2–8 °C under argon retains compliance with all listed parameters for 24 months from the date of manufacture, validated through ICH Q1A(R2)-style accelerated aging at 40 °C / 75 % RH for 6 months with no specification drift outside precision limits of the release methods.
    Property2-Bromothiazole2-Chlorothiazole2-IodothiazoleMethod Basis
    CAS3034-53-53034-52-43034-55-7
    Molecular weight (g·mol⁻¹)164.00119.57211.02
    Boiling point (°C)171143195 (dec.)ASTM D86 (modified)
    Refractive index nD201.5931.5511.648ASTM D1218
    GC purity, typical release (%)≥97.0≥95.0≥96.0 (stabilized with Cu wire)USP <621>
    Primary stability concernHydrolysisLow reactivityPhotolytic deiodination
    When Tetrachloroethane Replaces Methylene Chloride in Immersion Stripping In industrial degreasing and solvent-assisted resin removal, halogenated thiazoles occasionally appear as high-boiling additives, though this is a niche role. 2-Bromothiazole itself is not a formulated solvent but has been evaluated as a reactive diluent intermediate for thiophilic extraction agents. The miscibility gap with aliphatic hydrocarbons is pronounced; the compound remains fully homogeneous in toluene, THF, or DMF at 25 °C at all dilutions, whereas phase separation occurs with n-hexane when the thiazole fraction drops below 15 % v/v, as determined by turbidimetric titration (Tepper & Smith, J. Heterocycl. Chem.). This behavior must be accounted for when designing biphasic workup protocols after cross-coupling, as direct hexane extraction can selectively partition unreacted 2-bromothiazole into the polar phase, complicating mass recovery.

    Agrochemical Intermediacy and the Thiazole–Pyridine Bioisostere Concept

    The 2-thiazolyl moiety functions as a metabolic soft spot in early-generation neonicotinoid analogs; substitution with bromine at the 2-position furnishes a latent leaving group that can be elaborated into sulfoximine, cyano, or trifluoromethyl pharmacophores. Many commercial fungicidal lead series published by the agrochemical division of Syngenta and Bayer CropScience in the patent literature employ 2-bromothiazole as a late-stage diversification handle on a 1,2,4-triazole core. In a representative sequence, clean sodium-halogen exchange with n-BuLi at −78 °C in THF, followed by quenching with dimethylformamide, yields thiazole-2-carboxaldehyde in 82 % isolated yield after acidic workup—a two-step transformation that is unreliable with the chloro analog due to competing deprotonation at the ring 5-position (pKa29 in THF for the thiazole proton 5). This regiochemical fidelity is a direct consequence of bromine’s ability to direct metalation via halogen–lithium exchange without the extreme base strengths required for deprotonative metalation of 2-chlorothiazole. During research-scale synthesis, the homogeneity of commercially supplied material across batches exerts a measurable impact on the robustness of lithium-halogen exchange. Uncontrolled moisture in the batch elevates the BuLi consumption factor, shifting stoichiometry and generating lithium hydroxide that precipitates as a fine suspension, altering heat-transfer characteristics in jacketed vessels. End users operating in kilo-laboratory settings routinely implement a pre-drying step (4 Å sieves, 16 h) while monitoring water by inline KF before initiating the cryogenic step, a precaution codified in internal standard operating procedures aligned with ISO 14644-1 Class 8 cleanroom protocols.
    ParameterDevelopment Grade (≥97 %)GMP Grade (≥99 %)Analytical Method
    Assay (GC)≥97.0 %≥99.0 %USP <621>, Restek Rtx-5
    Any single impurity≤1.5 %≤0.3 %Internal normalization (GC-FID)
    Water (KF)≤500 ppm≤100 ppmASTM E203
    Residual solvents (headspace GC-MS)≤0.5 % (THF, DMF)≤0.05 %Ph. Eur. 2.4.24
    Heavy metals (Pb, Pd)Not controlled≤10 ppm eachICP-MS (USP <233>)
    Where a coupling reaction must produce an active pharmaceutical intermediate under ICH Q3A(R2) guidelines for genotoxic impurities, the development-grade material is often insufficient. Palladium-catalyzed amination with a primary aniline in a toluene/t-BuOH mixed-solvent system yields a product that may harbor residual 2-bromothiazole as a potential DNA-reactive species if not purged below the Threshold of Toxicological Concern. Switching to a high-purity lot (≥99 %) with individual brominated impurities capped at 0.3 % removes this flagged impurity risk without requiring chromatographic reprocessing post-coupling, saving 1–2 days in campaign timeline and eliminating a silica gel rework step that contributed 14 % mass loss on average across three validation batches.

    Migratory Tendencies and Polymer Matrix Compatibility

    Although not a traditional plastic additive, 2-bromothiazole has been investigated as a reactive grafting intermediate for polyolefin functionalization. When fed into a Leistritz ZSE 27 MAXX twin-screw extruder (L/D = 48, 27 mm screw diameter) at a barrel temperature profile of 180→210→220→200 °C (die) and a throughput of 15 kg·h⁻¹, the compound grafts onto maleic anhydride-modified polyethylene via thiol-ene click chemistry post-extrusion. Residual free 2-bromothiazole migration into food simulants was quantified under EU 10/2011 (simulant D2, 60 °C, 10 days) using LC-MS/MS with a limit of quantification of 0.1 µg·kg⁻¹. Concentrations remained below the 10 µg·kg⁻¹ threshold set for non-intentionally added substances when the initial grafting level did not exceed 1.5 wt %. Published data on long-term extractables under gamma irradiation (sterilization dose 25–40 kGy) are sparse. Limited accelerated-aging studies conducted in phosphate-buffered saline at 50 °C for 72 h indicated that leachables profiles were dominated by thiazole and inorganic bromide ion, with 2-bromothiazole itself undetectable by static headspace GC-MS when the compounded resin was pre-annealed at 80 °C for 4 h under vacuum. These findings are indicative but not exhaustive for regulatory submission; a full ISO 10993-18 chemical characterization with exhaustive extraction remains necessary for patient-contacting device applications.